ARTICLE | Clinical News
RHB-105: Phase III data
June 22, 2015 7:00 AM UTC
Top-line data from the double-blind, placebo-controlled, U.S. Phase III ERADICATE Hp trial in 118 patients with confirmed H. pylori infection and non-investigated dyspepsia showed that thrice-daily or...